Occlutech Atrial Flow Regulator*

* Occlutech Atrial Flow Regulator (AFR) is under clinical investigation – not approved for sale.

Clinical Trials

The PROPHET Trial

Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension

The PRELIEVE Trial

Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients (PRELIEVE)





The products shown may not be available in all markets. Availability for a specific therapeutic purpose, in any specific country or region, is subject to obtaining necessary regulatory clearance.